Botanical species · safety record

Camelina sativa

The EFSA Compendium of Botanicals holds 7 constituent measurements for Camelina sativa. This page reports what those source records contain and how to reach them. It carries no effect estimate, no dose and no recommendation.

Accepted name in source: Camelina sativa (L.) Crantz

7Constituent measurements
0Safety records
5Cited sources
15Licensed products (Canada)

Regulatory presence

Health Canada's Licensed Natural Health Products Database holds 15 licensed products naming Camelina sativa as a medicinal ingredient, matched on the exact Latin binomial. A licence records that a product met the regulator's requirements for sale in Canada. It is not evidence that the product works.

Source material stated

  • Grain(s)
  • Oil
  • Seed
  • Seed oil
  • Seed(s)

What the records describe

Constituents measured

  • Sinapine2
  • Calystegines1
  • Glucosinolates1
  • Lignans, total1
  • Phytic acid1
  • Sum of glucosinolates1

Plant parts

  • Seed6
  • Leaves1

Preparations

  • Drying (dehydration)5
  • Solvent extraction2

Recorded constituents

What analytical work has found in this species, at which plant part and preparation. A measured constituent is a fact about material, not about effect.

SubstancePlant partPreparationConcentrationAnalytical methodSource
GlucosinolatesSeedDrying (dehydration)36.3 Millimole/kilogramGaschromatography (GC)Resolve DOI
Lignans, totalSeedDrying (dehydration)5976 Microgram/100 gramGC-FIDResolve DOI
SinapineSeedSolvent extraction4 Milligram/gramUnspecifiedResolve DOI
Sum of glucosinolatesSeedSolvent extraction18.6 Millimole/kilogramUnspecifiedResolve DOI
CalysteginesLeavesDrying (dehydration)GC-MSNo resolvable identifier
Phytic acidSeedDrying (dehydration)29.9 Gram/kilogramClassification not possibleNo resolvable identifier
SinapineSeedDrying (dehydration)2.32 Gram/kilogramHigh Performance Liquid Chromatography (HPLC)/Liquid Chromatography (LC)No resolvable identifier

Cited sources

The literature the compendium cites for this species. Metatron Health has no relationship with these authors or journals and earns nothing from citing them.

  1. Matthaus, B., Angelini, LG. Anti-nutritive constituents in oilseed crops from Italy. INDUSTRIAL CROPS AND PRODUCTS, 2005, vol. 21, no. 1, p. 89-99. DOI
  2. Russo, Roberto., Reggiani, Remo. Antinutritive compounds in twelve Camelina sativa genotypes. American Journal of Plant Sciences, 2012, p. 1408-1412.
  3. Smeds, Annika I., Eklund, Patrik C., Willfor, Stefan M. Content, composition, and stereochemical characterisation of lignans in berries and seeds. FOOD CHEMISTRY, 2012, vol. 134, no. 4, p. 1991-1998. DOI
  4. Kahindi, R. K., Woyengo, T. A., Thacker, P. A., Nyachoti, C. M. Energy and amino acid digestibility of camelina cake fed to growing pigs. ANIMAL FEED SCIENCE AND TECHNOLOGY, 2014, vol. 193, p. 93-101. DOI
  5. Brock, Andrea., Herzfeld, Tobias., Paschke, Reinhard., Koch, Marcus., Draeger, Birgit. Brassicaceae contain nortropane alkaloids. Phytochemistry (Elsevier), 2006, p. 2050-2057.

Boundary

A constituent measurement is a fact about material at a stated preparation, not a statement about what that material does in a person. An adverse-effect or genotoxicity record is an observation reported in a source, most often in an animal or laboratory model. Neither is a Metatron Health conclusion about causality, human risk or benefit, and the absence of a record is not proof that a preparation is safe. Nothing here is diagnosis, prescribing or individual medical care.

Continue